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If I were to informally survey 100 prospective medical
students, asking all of them the same question, “Why do you
want to be a doctor?” I suspect that at least 90 would reply
with some variation on “I want to help people.” A similar
study of seasoned physicians, asked why they chose medi-
cine and why they spent a dozen or more years in training,
would probably yield similar answers. The desire to “help
people”—to make them well or ease their suffering—is the
common thread running through the community of physi-
cians. It is what most of us do all day long.
I suspect that, among physicians, there are other common
traits as well. We are a hard-working, ambitious group,
driven to succeed, willing to give up time for ourselves and,
in some circumstances, even for our families, for the good of
our patients. We are quick thinking and confident in our
instincts and our abilities. These attributes are the products
of our training—the long hours we logged as fellows, the
pressure we felt to deliver the right answer while on hospital
rounds, and the burden of knowing that the decisions we
made might save or end a life. No doubt, it takes a great deal
of self-assurance to deal in life and death.
So, it’s hardly surprising that many physicians are dis-
tressed, offended, even angered by the “quality assurance”
movement that is making headlines these days. Since the
early days of medicine, physicians have worked autono-
mously. Yes, we have relied on nurses and technicians, but
there has still been a certain mystique about being the
doctor. And, now, we find at every turn someone question-
ing our judgment…payers, government agencies, hospital
committees, even our patients. And some of these parties
don’t stop at just asking questions; some seem to threaten
us—with “profiling,” report cards, outcomes monitoring,
analysis of practice variation…the list of ways they want to
“measure” our work seems endless.
Making the situation worse is that the “quality” that these
parties are demanding that we demonstrate often appears to
be a moving target. The “best practice” that I learned during
my training more than 30 years ago (although it wasn’t
called that) is a far cry from today’s “state-of-the-art” care.
And I wouldn’t be surprised to hear some of the physicians
I trained in the past decade say something similar. It’s not
that any of us was poorly trained. That excellence, and our
achievements, have made possible the extraordinary
progress we have realized in the management of cardiovas-
cular disease. Ironically, those achievements are what have
made much of what we learned back then history already.
As Blumenthal (1) has noted: “A hundred years ago,
everything physicians needed to treat their patients was
found between their own two ears or in a small black bag.”
We have moved light years from that capability. Today, it is
not humanly possible for any individual to keep up with
what Chassin and Galvin (2) call the “avalanche of efficacy
data” that should be informing how each of us delivers care.
Compounding this dilemma is the fact that it is impossible
for any physician to care for patients with complete auton-
omy. Because we now realize the complexity of most
diseases and because every scientific discipline has grown
more and more specialized, the simple biology we relied on
to make clinical judgments in the past has metamorphosed
into biochemistry, biophysics, bioethics, bioenergetics, and
biogenetics—to name only a few. Clinical care of a single
patient often becomes so complex that it must be expanded
to include many other health care experts, which means that
systems and processes often determine outcomes. I can be
the best cardiologist around, but if I do not work in an
efficient and expert system that includes nurses, technicians,
and others, my expertise may become lost. In short, the
target all of us were shooting for when we started treating
patients has moved.
These are just some of the reasons that the quality-of-care
concept represents frustration for many physicians. But,
here’s the kicker—I would argue that each of these reasons
is exactly why it behooves us as physicians to embrace the
quality-of-care movement. And, more important is that this
movement will help us to do a better job of what all of us set
out to do when we became doctors: help people.
“QUALITY” DEFINED
If we, as a community of physicians, can agree that it is in
the best interests of both our patients and our profession to
embrace the quality-of-care initiatives now being under-
taken in so many sectors of society, then a logical place to
start is to examine what “quality” is and what it is not. As
Blumenthal (1) has pointed out, the struggle to define this
term has led to varied definitions, from descriptions set
forth by the American Medical Association to characteris-
tics outlined by individual patient groups, managed-care
organizations, public agencies, and insurance programs. In
1994, the Institute of Medicine convened a roundtable
representing these and other perspectives, including aca-
demia, business, consumers, federal programs, the private
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sector, and the media. The group agreed on the following
definition:
“Quality of care is the degree to which health services for
individuals and populations increase the likelihood of de-
sired health outcomes and are consistent with current
professional knowledge” (2).
The College is not entirely sure that this is the right
definition, but it is a good place to begin. Chassin and
Galvin (2) have also investigated problems indicative of
poor quality. Noting that, “At its best, health care in the
United States is superb,” these researchers added that there
are three categories into which problems detracting from
quality can be grouped: underuse, overuse, and misuse.
Underuse occurs when therapies proven to be effective are
not provided. Chassin and Galvin (2) cited several effica-
cious drug therapies for acute myocardial infarction (AMI)
patients that are underused. They suggested that 18,000
deaths might be prevented each year in the U.S. if physi-
cians more routinely prescribed thrombolytics, beta-
blockers, and ACE inhibitors to AMI patients. In contrast,
overuse occurs when a procedure or service is provided for
clearly inappropriate indications. I suspect that when insur-
ance companies or managed-care organizations try to dic-
tate to physicians which procedures are necessary, they are
relying on overuse statistics as their justification. And,
finally, misuse occurs when an appropriate service is deliv-
ered but preventable complications develop and the patient
fails to fully benefit from the care.
QUALITY: PROGRESS AND TOOLS
The group also agreed that it is possible to measure quality,
although doing so is a daunting task. They noted that some
tools are already available but that many are being devel-
oped. In accordance with its mission, the American College
of Cardiology (ACC) has been participating in quality-of-
care efforts for approximately 20 years, beginning with the
development of practice guidelines. In more recent years, we
have expanded our efforts significantly in pursuit of means
to help our members hit the target of delivering optimal
care.
I believe that one of the most important facts to keep in
mind when thinking about the College and quality is this:
The ACC is a member-led and member-driven organiza-
tion. This means that there are physicians—not payers, not
government agencies, not administrators, and not even
patients—driving all of our activities, including quality.
This fact will serve us well in many regards:
● First, we physicians have the best likelihood of being
effective. Who understands the day-to-day rigors of
practicing medicine better than doctors?
● Second, leading the way in quality-of-care initiatives is an
excellent way for us to demonstrate to our patients and
their families that we are looking out for them, that we are
“reforming” health care and not in need of reform
ourselves.
● Third, as Chassin (3) has written, “By specifying what
quality means and how it should be measured, physicians
will specify how medicine should be practiced.” In other
words, by tackling the problems in health care delivery,
we are taking important steps toward maintaining our
autonomy.
The College’s investment in quality-of-care efforts is already
significant, and our initiatives are numerous and diverse.
These efforts have arisen based on opportunities, and the
time has come for us to be more strategic. I have charged the
newly created Task Force on Science and Quality of Care to
help the College develop an overall strategy and objectives
that will direct our movement forward and ensure that we
have recognized and seized the best opportunities for the
College’s programs in quality. The task force will complete
its work by March 2002, and I look forward to sharing its
recommendations with you. In the meantime, here is a brief
overview of where we are today:
Practice guidelines. The Institute of Medicine (4) defines
practice guidelines as “systematically developed statements
to assist practitioner and patient decisions about appropriate
health care for specific clinical circumstances.” The College
has a long history in practice guidelines. With the American
Heart Association (AHA), the College undertook its first
practice guideline in 1980, when a number of organizations
were just breaking into this area. In subsequent years,
dozens of guidelines have been published, and 16 are
currently in print and available for download from the ACC
Web site. A discussion of these guidelines and their enor-
mous potential to beneficially influence the care of cardio-
vascular patients will be the subject of a future President’s
Page. In the meantime, I want simply to emphasize that
practice guidelines are developed through a rigorous process
conducted by expert physicians. The writing groups spend
months culling through all of the literature about the subject
condition or procedure and filtering out findings that are
not yet supported by professional experience. These guide-
lines are a major help to practicing physicians, who do not
have the time to synthesize the extensive evidence derived
from population-based studies and apply it to individual
patients.
Performance measures. A relatively new undertaking for
the ACC and the AHA, performance measures translate the
key recommendations from the guidelines into measures
that we clinicians can use to assess and improve quality of
care. The first two sets of ACC/AHA performance mea-
sures—on AMI and heart failure—will be published early
next year. Although performance measures, like many other
quality initiatives, are based on practice guidelines, they are
usually a small set of measurable items that individual
cardiovascular care providers can use. For example, once
completed, the AMI performance measures might be six to
ten questions, including: “Did you prescribe aspirin to
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patients with AMI who did not have major contraindica-
tions?” The key here is to be able to track back to the
guideline, which in this case recommends the use of aspirin
for all patients except those with a true aspirin allergy and to
be careful with those who have a history of upper gastroin-
testinal bleeding. This way, the behavior being measured is
one that the best available evidence suggests bears an
important relationship to patient outcome. During a given
week, I would look at all of the AMI patients I encountered
and measure which of the items I did or did not do. At the
end of the week, I could see how I measure up to the ideal.
And the best things about performance measures are that
the “ideal” is the recommendation of my peers and other
cardiovascular care providers who are as interested as I am in
quality care and that I do the measuring myself, for myself.
Clinical data standards. An important task the ACC has
set for itself is to promote consistency among data-
collection efforts, whether they are clinical studies, registries
of clinical data, or published articles related to patient care.
By identifying the best definitions and standards for clinical
care and research, data standards will go a long way toward
this goal. Just this fall, the College published its first set of
data standards. This document focuses on acute coronary
syndromes (ACS) and provides a common terminology for
describing the care and outcomes of patients with ACS.
The group that drafted these standards invested more than
three years in getting them right, including a period when
the draft document was posted on the ACC Web site and
comments from physicians, researchers, hospitals, payers,
and others were welcomed. Standards for heart failure and
atrial fibrillation are in progress.
GAP program. The Guidelines Applied in Practice, or
GAP, program is one of the College’s most exciting and
rewarding projects. The GAP program takes guidelines off
the shelf, where they too often go unheeded, and puts them
into practice. The first GAP Project was conducted in
Southeast Michigan in collaboration with the Greater
Detroit Area Health Council and the state’s peer review
organization. Concentrating on AMI, this GAP Project
spanned just 12 months and achieved significant results in
that short time. Using a kit full of tools designed to help
physicians and other health care providers, as well as
patients and their families, the project yielded what its
principal investigator, Dr. Kim Eagle, calls “striking” re-
sults. The GAP team assessed the impact of the tools,
including checklists, standing orders, chart stickers, and a
flight plan for patients being treated after an AMI, on more
than 800 patients in 10 hospitals in the Detroit area.
For virtually every key quality indicator, GAP resulted
in either a positive trend or a significant improvement
in adherence to the recommendations in the guideline.
Following the GAP initiative, more AMI sufferers were
being advised to kick the smoking habit. The most impres-
sive results were seen in Medicare patients. In addition to
the fact that more of these patients received beta-blockers in
the first 24 h after hospital admission, these patients were
significantly more likely to be given aspirin during the
first day of their hospital stay and on discharge from the
hospital.
Following the enormous success of the first project, the
College has launched two new GAP initiatives. Alabama is
the site for a GAP Project on stable angina, and Oregon will
host a project focused on heart failure. In the meantime, the
College is working with the AHA to develop a program that
unites the GAP program with the AHA’s “Get With the
Guidelines” program, which has similar aims and ap-
proaches.
National Cardiovascular Data RegistryTM. A critical re-
quirement for quality improvement is the ability to measure
performance and to compare your performance with others
like you. Such measurement permits opportunities for im-
provement to be identified, and the impact of intervention
on performance then can be monitored. The ACC has
made a considerable investment in supporting the efforts of
catheterization laboratories to measure the quality of care
they provide to patients undergoing diagnostic catheteriza-
tions and percutaneous coronary interventions. The ACC-
National Cardiovascular Data RegistryTM (NCDR) service
currently provides comparative reports to assist its more
than 300 subscribers in understanding and improving the
quality of their results. The ACC-NCDRTM database is also
an incredible resource for ACC members, many of whom
have begun to use it to answer important research questions
and to produce a stream of abstracts and papers that I expect
will be a river before long.
The cath lab “Continous Quality Improvement” (CQI)
tool kit. Although the ACC-NCDRTM is a first step
toward improving quality in this arena, performance infor-
mation alone—without tools that lead to improvement—
creates frustration rather than higher-quality care. So, the
College’s next step is to develop a broad-based “tool kit”
that will provide the recommendations, guides, and tem-
plates needed to translate identified opportunities for im-
provement into the delivery of better care. The tool kit is in
an early stage of development, and we expect that a
prototype will be ready for testing in 2002.
CONCLUSION
In previous President’s Pages, I have discussed issues related
to education and advocacy. Recently, I outlined ACCardio,
the College’s endeavor to provide a knowledge management
system that will help cardiovascular specialists and other
health care providers to stay current in the field and to access
information on an as-needed basis. In other issues of the
Journal of the American College of Cardiology, I have discussed
our advocacy efforts and the important step we are taking by
establishing a political action committee and creating new
resources for our chapters and grassroots lobbying. These
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and other initiatives in education and advocacy are crucial to
quality care. When we can easily obtain the latest research
findings, we will be in a better position to give our patients
state-of-the-art care. Likewise, maintaining an environment
in which we are able to provide the care our patients need,
unrestrained by unnecessary regulations or payer protocols,
will serve our patients.
The issue of quality is pertinent for everyone at the ACC
and for all of its members. The notion of “continuous
quality improvement” is driving all of our efforts. We all
weather the frustrations that sometimes accompany
progress, realizing that achieving quality is not a destination
but rather a journey toward a constantly moving target. We
will never “get there,” but we must keep striving to move in
that direction.
Reprint requests and correspondence: Douglas P. Zipes, MD,
FACC, Indiana University School of Medicine, Krannert Institute
of Cardiology, 1800 North Capitol Street, Indianapolis, Indiana
46202.
REFERENCES
1. Blumenthal D. Quality of care—What is it? N Engl J Med 1996;335:
891–4.
2. Chassin MR, Galvin RW. The urgent need to improve health care
quality: Institute of Medicine National Roundtable on Health Care
Quality. JAMA 1998;280:1000–5.
3. Chassin MR. Improving the quality of care. N Engl J Med 1996;335:
1060–3.
4. Institute of Medicine. Clinical Practice Guidelines: Directions for a
New Program. Washington, DC: National Academy Press, 1990.
1769JACC Vol. 38, No. 6, 2001 Zipes
November 15, 2001:1766–9 President’s Page
